Related references
Note: Only part of the references are listed.Reduced obesity, diabetes, and steatosis upon cinnamon and grape pomace are associated with changes in gut microbiota and markers of gut barrier
Matthias Van Hul et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2018)
Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes
Liping Zhao et al.
SCIENCE (2018)
Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut
Jacobo de la Cuesta-Zuluaga et al.
DIABETES CARE (2017)
Akkermansia muciniphila improves metabolic profiles by reducing inflammation in chow diet-fed mice
Shaoqian Zhao et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2017)
Chlorogenic Acid Ameliorates Experimental Colitis by Promoting Growth of Akkermansia in Mice
Zhan Zhang et al.
NUTRIENTS (2017)
Anti-diabetic effects and mechanisms of action of a Chinese herbal medicine preparation JQ-R in vitro and in diabetic KKAY mice
Quan Liu et al.
ACTA PHARMACEUTICA SINICA B (2017)
Association between acute gastrointestinal injury and biomarkers of intestinal barrier function in critically ill patients
Hongxiang Li et al.
BMC GASTROENTEROLOGY (2017)
Simultaneous determination of four phenolic acids and seven alkaloids in rat plasma after oral administration of traditional Chinese medicinal preparation Jinqi Jiangtang Tablet by LC-ESI-MS/MS
Yan-xu Chang et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2016)
Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function
Caleb J. Kelly et al.
CELL HOST & MICROBE (2015)
Alterations of gut barrier and gut microbiota in food restriction, food deprivation and protein-energy wasting
L. Genton et al.
CLINICAL NUTRITION (2015)
Disposition of Astragaloside IV via Enterohepatic Circulation Is Affected by the Activity of the Intestinal Microbiome
Yi Jin et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2015)
The multi-targets integrated fingerprinting for screening anti-diabetic compounds from a Chinese medicine Jinqi Jiangtang Tablet
Yan-xu Chang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2015)
Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
Kristoffer Forslund et al.
NATURE (2015)
The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design
Xiao Sun et al.
TRIALS (2015)
The composition of the gut microbiota shapes the colon mucus barrier
Hedvig E. Jakobsson et al.
EMBO REPORTS (2015)
A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice
Fernando F. Anhe et al.
GUT (2015)
Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice
Marc Schneeberger et al.
SCIENTIFIC REPORTS (2015)
Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits
Filipe De Vadder et al.
CELL (2014)
Adipocyte Inflammation Is Essential for Healthy Adipose Tissue Expansion and Remodeling
Ingrid Wernstedt Asterholm et al.
CELL METABOLISM (2014)
An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice
Na-Ri Shin et al.
GUT (2014)
A refined-JinQi-JiangTang tablet ameliorates prediabetes by reducing insulin resistance and improving beta cell function in mice
Li-hui Gao et al.
JOURNAL OF ETHNOPHARMACOLOGY (2014)
Chlorogenic Acid Decreases Intestinal Permeability and Increases Expression of Intestinal Tight Junction Proteins in Weaned Rats Challenged with LPS
Zheng Ruan et al.
PLOS ONE (2014)
Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics
L. Geurts et al.
BENEFICIAL MICROBES (2014)
Berberine Reduces Rat Intestinal Tight Junction Injury Induced by Ischemia-Reperfusion Associated with the Suppression of Inducible Nitric Oxide Synthesis
Lili Gu et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2013)
Diabetes, obesity and gut microbiota
Amandine Everard et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2013)
Ischaemia-induced mucus barrier loss and bacterial penetration are rapidly counteracted by increased goblet cell secretory activity in human and rat colon
Joep Grootjans et al.
GUT (2013)
Astragalus polysaccharide reduces inflammatory response by decreasing permeability of LPS-infected Caco2 cells
Xiaofei Wang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2013)
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Amandine Everard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome
Anne Vrieze et al.
GASTROENTEROLOGY (2012)
A metagenome-wide association study of gut microbiota in type 2 diabetes
Junjie Qin et al.
NATURE (2012)
Structural Changes of Gut Microbiota during Berberine-Mediated Prevention of Obesity and Insulin Resistance in High-Fat Diet-Fed Rats
Xu Zhang et al.
PLOS ONE (2012)
Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity
Patrice D. Cani et al.
GUT MICROBES (2012)
Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability
P. D. Cani et al.
GUT (2009)
Review article: the role of butyrate on colonic function
H. M. Hamer et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
Fredrik Backhed et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Akkermansia muciniphila gen. nov., sp nov., a human intestinal mucin-degrading bacterium
M Derrien et al.
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (2004)
Share Paper
